Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

The synthetic triterpenoid, CDDO, suppresses alloreactive T cell responses and reduces murine early acute graft-versus-host disease mortality.

Sun K, Li M, Konopleva M, Konoplev S, Stephens LC, Kornblau SM, Frolova O, Wilkins DE, Ma W, Welniak LA, Andreeff M, Murphy WJ.

Biol Blood Marrow Transplant. 2007 May;13(5):521-9. Epub 2007 Feb 26.

PMID:
17448911
[PubMed - indexed for MEDLINE]
2.

The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.

Li M, Sun K, Redelman D, Welniak LA, Murphy WJ.

Biol Blood Marrow Transplant. 2010 Jun;16(6):739-50. doi: 10.1016/j.bbmt.2010.01.020. Epub 2010 Mar 23.

PMID:
20338256
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.

Bäuerlein CA, Riedel SS, Baker J, Brede C, Garrote AL, Chopra M, Ritz M, Beilhack GF, Schulz S, Zeiser R, Schlegel PG, Einsele H, Negrin RS, Beilhack A.

BMC Med. 2013 May 21;11:134. doi: 10.1186/1741-7015-11-134.

PMID:
23692886
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Prophylactic effect of TLR5 agonist flagellin on acute graft versus host disease after allogeneic hematopoietic stem cell transplantation and its mechanism].

Gong XD, Ma LM, Zhu L, Guo HM, Ren LS, Ren RR, Zhang HP, Wei F, Niu YY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):965-70. Chinese.

PMID:
22931665
[PubMed - indexed for MEDLINE]
5.

The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.

Li Z, Wu Q, Yan Z, Li D, Lu G, Mou W, Wu S, Pan X, Lu Q, Xu K.

Transplant Proc. 2013 Jul-Aug;45(6):2527-35. doi: 10.1016/j.transproceed.2013.03.042.

PMID:
23953575
[PubMed - indexed for MEDLINE]
6.

The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in mice.

Ames E, Harouna S, Meyer C, Welniak LA, Murphy WJ.

Biol Blood Marrow Transplant. 2012 Mar;18(3):396-405. doi: 10.1016/j.bbmt.2011.11.013. Epub 2011 Nov 17.

PMID:
22100978
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.

Wang J, Li L, Xu M, Rong R, Zhu T.

Transplantation. 2013 Nov 15;96(9):774-81. doi: 10.1097/TP.0b013e3182a1931f.

PMID:
23900211
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.

Ewing P, Hildebrandt GC, Planke S, Andreesen R, Holler E, Gerbitz A.

Int J Mol Med. 2007 Sep;20(3):301-8.

PMID:
17671733
[PubMed - indexed for MEDLINE]
9.

Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease.

Tobin LM, Healy ME, English K, Mahon BP.

Clin Exp Immunol. 2013 May;172(2):333-48. doi: 10.1111/cei.12056.

PMID:
23574329
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.

Tran TA, McCoy MK, Sporn MB, Tansey MG.

J Neuroinflammation. 2008 May 12;5:14. doi: 10.1186/1742-2094-5-14.

PMID:
18474101
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe₃O₄ combined with cyclosporin A in murine models.

Cheng J, Zhou Y, Chen B, Wang J, Xia G, Jin N, Ding J, Gao C, Chen G, Miao Y, Li W, Liu Z, Wang X.

Int J Nanomedicine. 2011;6:2183-9. doi: 10.2147/IJN.S24567. Epub 2011 Oct 3.

PMID:
22114482
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.

Hartwig UF, Robbers M, Wickenhauser C, Huber C.

Blood. 2002 Apr 15;99(8):3041-9.

PMID:
11929798
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of exercise interventions in graft-versus-host disease models.

Fiuza-Luces C, González-Murillo A, Soares-Miranda L, Martínez Palacio J, Colmenero I, Casco F, Melén G, Morán M, Lucia A, Ramírez M.

Cell Transplant. 2013;22(12):2409-20. doi: 10.3727/096368912X658746. Epub 2012 Oct 31.

PMID:
23127525
[PubMed - indexed for MEDLINE]
15.

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.

Jones SC, Murphy GF, Korngold R.

Biol Blood Marrow Transplant. 2003 Apr;9(4):243-56.

PMID:
12720217
[PubMed - indexed for MEDLINE]
16.

[Prophylactic effect of matrix metalloproteinase inhibitor on acute graft-versus-host disease in a murine model].

Gu Y, Liu CF.

Zhonghua Xue Ye Xue Za Zhi. 2006 Aug;27(8):515-7. Chinese.

PMID:
17172122
[PubMed - indexed for MEDLINE]
17.

Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.

Kress CL, Konopleva M, Martínez-García V, Krajewska M, Lefebvre S, Hyer ML, McQueen T, Andreeff M, Reed JC, Zapata JM.

PLoS One. 2007 Jun 27;2(6):e559.

PMID:
17593960
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice.

Saha PK, Reddy VT, Konopleva M, Andreeff M, Chan L.

J Biol Chem. 2010 Dec 24;285(52):40581-92. doi: 10.1074/jbc.M110.176545. Epub 2010 Oct 18.

PMID:
20956520
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].

Cavazzana-Calvo M, André-Schmutz I, Hacein-Bey S, Schindler J, Vitetta H, Dupuis S, Quartier P, Chedeville G, Vilmer E, Casanova JL, Buffet R, Caillat-Zucman S, Radford I, Le Deist F, Fischer A.

J Soc Biol. 2001;195(1):65-8. French.

PMID:
11530503
[PubMed - indexed for MEDLINE]
20.

Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.

Giver CR, Montes RO, Mittelstaedt S, Li JM, Jaye DL, Lonial S, Boyer MW, Waller EK.

Biol Blood Marrow Transplant. 2003 Oct;9(10):616-32.

PMID:
14569558
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk